Newel Health | pharmaphorum

Skip to main content

Tuesday 3 December 2024

twitter linkedin facebook rss

User account menu

Subscribe

Channels

Content type

Categories

Categories

Sort by

Order

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

close

Channels

Content type

Categories

Categories

Sort by

Order

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

Sign up

twitter linkedin facebook rss

Sign in

Newel Health

News

Orion Corp's Rohkea

Orion and Newel Health sign licensing agreement for VR DTx

Finland’s Orion Corp has entered into a licensing agreement with digital therapeutics (DTx) specialist Newel Health, handing over rights to an app designed to support pati

News

Enrolment starts in trial of AI-powered Parkinson’s therapy

Enrolment starts in trial of AI-powered Parkinson’s therapy

Patient recruitment is now underway in a clinical trial of Newel Health’s digital therapeutic for Parkinson’s disease, which hopes to show it can enhance the efficacy of t

Digital

Soturi

Newel Health begins next phase of development of Soturi

Soturi, Newel Health’s digital therapeutics solution for Parkinson’s Disease (PD), has begun the next phase of development, aiming to v

Digital

Newel Health's Soturi

Newel Health scores $2.5M from MJFF for Parkinson’s app

Newel Health has been awarded a $2.5 million USD grant from the Michael J.

Digital

Newel Health + Soturi

Partner Content

Newel Health awarded $2.5M Michael J. Fox research grant

Newel Health has been awarded a $2.5 million research grant from The Michael J. Fox Foundation.

Editor's Picks

Halozyme abandons its €2bn pursuit of Evotec

Sanofi opens $595m manufacturing facility in Singapore News

Neuralink unveils trial linking brain implant to robotic arm

Biden ramps up Medicare coverage of obesity drugs

Makary confirmed as Trump's FDA pick, with Weldon for CDC

Digital

Man listen to audio with headphones

Seeking effective, safe treatment for all with precision dos...

Modern medicine moves ever more to precision, personalised medicine, and precision dosing is critical in a world that recognises biological individuality – especially when it comes to paedi

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Digital

The AI effect in pharma commercial strategy: From data to real-time insight & actions

Sponsored

The AI effect in pharma commercial strategy: From data to re...

Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Subscribe

rss facebook linkedin twitter

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company